Eczeem en antimicrobiële therapie

D. J. Hijnen

Eczeem en antimicrobiële therapie

Translated title of the contribution: Eczema and antimicrobial therapy

D. J. Hijnen^*

^*Corresponding author for this work

University Medical Centre Utrecht

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Most patients with atopic dermatitis (AD) are colonized with Staphylococcus aureus. Moreover, infection with S. aureus is more common in AD patients compared to normal controls. Although a role for S.aureus in the pathogenesis AD has long been accepted, the exact mechanisms by which S. aureus interacts with the skin immune system need to be elucidated. Multiple factors, including superantigens may play an important role. New therapies targeting the cross-talk between microbes and the host, or directly targeting of microbiome will be discussed.

Translated title of the contribution	Eczema and antimicrobial therapy
Original language	Dutch
Pages (from-to)	114-116
Number of pages	3
Journal	Nederlands Tijdschrift voor Dermatologie en Venereologie
Volume	25
Issue number	3
Publication status	Published - 1 Sept 2015
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2015 De Nederlandse Vereniging voor Dermatologie en Venereologie.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{d962dbcb139341b184b961e9ceb2d533,

title = "Eczeem en antimicrobi{\"e}le therapie",

abstract = "Most patients with atopic dermatitis (AD) are colonized with Staphylococcus aureus. Moreover, infection with S. aureus is more common in AD patients compared to normal controls. Although a role for S.aureus in the pathogenesis AD has long been accepted, the exact mechanisms by which S. aureus interacts with the skin immune system need to be elucidated. Multiple factors, including superantigens may play an important role. New therapies targeting the cross-talk between microbes and the host, or directly targeting of microbiome will be discussed.",

author = "Hijnen, \{D. J.\}",

note = "Publisher Copyright: {\textcopyright} 2015 De Nederlandse Vereniging voor Dermatologie en Venereologie.",

year = "2015",

month = sep,

day = "1",

language = "Dutch",

volume = "25",

pages = "114--116",

journal = "Nederlands Tijdschrift voor Dermatologie en Venereologie",

issn = "0925-8604",

publisher = "Stichting Beheer Tijdschriften Dermatologie",

number = "3",

}

TY - JOUR

T1 - Eczeem en antimicrobiële therapie

AU - Hijnen, D. J.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Most patients with atopic dermatitis (AD) are colonized with Staphylococcus aureus. Moreover, infection with S. aureus is more common in AD patients compared to normal controls. Although a role for S.aureus in the pathogenesis AD has long been accepted, the exact mechanisms by which S. aureus interacts with the skin immune system need to be elucidated. Multiple factors, including superantigens may play an important role. New therapies targeting the cross-talk between microbes and the host, or directly targeting of microbiome will be discussed.

AB - Most patients with atopic dermatitis (AD) are colonized with Staphylococcus aureus. Moreover, infection with S. aureus is more common in AD patients compared to normal controls. Although a role for S.aureus in the pathogenesis AD has long been accepted, the exact mechanisms by which S. aureus interacts with the skin immune system need to be elucidated. Multiple factors, including superantigens may play an important role. New therapies targeting the cross-talk between microbes and the host, or directly targeting of microbiome will be discussed.

UR - https://www.scopus.com/pages/publications/84942435211

M3 - Article

AN - SCOPUS:84942435211

SN - 0925-8604

VL - 25

SP - 114

EP - 116

JO - Nederlands Tijdschrift voor Dermatologie en Venereologie

JF - Nederlands Tijdschrift voor Dermatologie en Venereologie

IS - 3

ER -

Eczeem en antimicrobiële therapie

Abstract

Bibliographical note

UN SDGs

Other files and links

Fingerprint

Cite this